   
  
G/TBT/N/BRA/1324/Add.1  
 
14 May 2024  
(24-3719) Page: 1/1 
Committee on Technical Barriers to Trade  Original: English  
 
NOTIFICATION  
Addendum  
The following communication , dated  13 May 2024, is being circulated at the request of the delegation 
of Brazil . 
 
_______________  
 
 
Title:  Resolution – RDC number 620, 09 March 2022  
 
Reason for Addendum:  
[ ] Comment period changed - date:   
[ ] Notified measure adopted - date:  
[ ] Notified measure published - date:  
[ ] Notified measure enters into force - date:  
[ ] Text of final measure available from1:  
[ ] Notified measure withdrawn or revoked - date:  
Relevant symbol if measure re -notified:   
[X] Content or scope of notified measure changed  and text available from1:  
https://antigo.anvisa.gov.br/documents/10181/3676755/RDC_858_2024_.pdf/3416e5
64-b181-4f93-9308-2580325bf310  
https://members.wto.org/crnattachments/2024/TBT/BRA/modification/24_03195_00_x
.pdf 
New dead line for comments (if applicable):   
[ ] Interpretive guidance issued and text available from1:  
[ ] Other:  
 
Description:  Resolution 620, 09 March 2022 - previously notified through G/TBT/N/BRA/1324 - 
which contains provisions on the Certification of Good Practices for conducting 
Bioavailability/Bioequivalence studies of medicaments and defines which 
Bioavailability/Bioequivalence studies of me dicines must be carried out in certified research centers, 
was changed by Resolution 858, 06 May 2024.  
__________  
 
 
 
1 This information can be provided by including a website address, a pdf attachment, or other 
information on where the text of the final /modified  measure and/or interpretive guidance can be obtained.  